This year the LSX World Congress will consist of three parts: a meeting focused on biotech; one focused on medtech and a third focused on healthtech. This reflects the fact that all three sectors continue to be a driving force for innovation and improving patient care and health outcomes. Attendees of this year's meeting are expected to include executives of companies in all three sectors, investors, service organisations and others.
Among the topics to be discussed are the state of the global capital markets and trends in sectors such as oncology, neurology and gene therapy. These panels will be led by executives of small and large biopharma companies who have extensive experience in their fields.
The meeting will take place at the Business Design Centre, 52 Upper Street, London N1 0QH, UK.
MedNous readers will be eligible to a 15% discount on the conference fee.